Efficacy and Safety of Replacing Lenalidomide with Pomalidomide ...

Johnson & Johnson to showcase strength of its broad hematology ...

Phase 3 Randomized Study of DARZALEX FASPRO ® + Bortezomib, Lenalidomide ... efficacy and safety of IMBRUVICA ® . IMBRUVICA ® was first approved ...

Sanofi - Aventis Groupe | Globenewswire - Via Ritzau

The safety and efficacy of Sarclisa has not been evaluated by any ... We provide potentially life-changing treatment options and life-saving ...

Johnson to showcase strength of its broad hematology portfolio and ...

Phase 3 Randomized Study of DARZALEX FASPRO® + Bortezomib, Lenalidomide ... efficacy and safety of IMBRUVICA®. IMBRUVICA® was first approved by ...

The safety and efficacy of Sarclisa has not been evaluated by any ... We provide potentially life-changing treatment options and life-saving ...

Isatuximab in combination with pomalidomide and dexamethasone ...

The study investigated the effectiveness and safety of this triple combination as a second-line treatment for patients who had previously been ...

Efficacy and safety of pomalidomide and low-dose dexamethasone ...

Methods: Adult (≥ 18 years of age) RRMM patients who progressed after at least two previous treatments, including bortezomib and lenalidomide, were eligible.

Clinical perspectives on the optimal use of lenalidomide plus ...

The combination of lenalidomide, bortezomib, and dexamethasone (RVd) has consistently demonstrated a tolerable safety profile with significant ...